Varicella vaccine reduces contagiousness of chickenpox

August 10, 2004

CHICAGO - Children and adolescents who have received the varicella (chickenpox) vaccine and contract varicella are about half as contagious as those who have not been vaccinated, according to a study in the August 11 issue of JAMA, the Journal of the American Medical Association.

According to background information in the article, varicella is a highly infectious disease caused by the varicella zoster virus, which is spread by droplet or airborne transmission. Before the varicella vaccination program in the United States, approximately 4 million varicella cases occurred each year, resulting in 10,600 hospitalizations and 100 deaths. The majority of cases occurred in children, which reflects the highly contagious nature of the disease. Limited data are available on the contagiousness of vaccinated varicella cases.

Jane F. Seward, M.B., B.S., M.P.H., of the Centers for Disease Control and Prevention, Atlanta, and colleagues examined varicella transmission within households according to the varicella history and vaccination status of both the primary case and exposed household member(s) and estimated vaccine effectiveness from household secondary attack rates. The study consisted of a population-based, active varicella surveillance project in a community of approximately 320,000 in Los Angeles County during 1997 and 2001. Varicella cases were reported by child care centers, private and public schools, and health care clinicians and were investigated to collect demographic, clinical, medical, and vaccination data. Information on household contacts' age, varicella history, and vaccination status was collected.

During the study period, 6,316 cases of varicella were reported. The researchers found that among children and adolescents aged 1 to 14 years, secondary attack rates varied according to age and by disease and vaccination status of the primary case and exposed household contacts. "Among contacts aged 1 to 14 years exposed to unvaccinated cases, the secondary attack rate was 71.5 percent if they were unvaccinated and 15.1 percent if they were vaccinated. Overall, vaccinated cases were half as contagious as unvaccinated cases. However, vaccinated cases with 50 lesions or more were similarly contagious as unvaccinated cases whereas those with fewer than 50 lesions were only one-third as contagious."

"As cases and the severe health burden from varicella further decline, monitoring age, severity, and vaccination status of the remaining varicella cases will become increasingly important. It is expected that with continuing increases in vaccine coverage, a higher propotion of cases will occur in vaccinated children. Further understanding of the severity and contagiousness of these cases in the community as well as in household settings will assist with future vaccine policy decisions," the authors conclude.
(JAMA. 2004;292:704-708. Available post-embargo at

Editor's Note: From 1997 through 2001, CDC funded the Los Angeles Department of Health Services under a co-operative agreement for Active Varicella Surveillance and Epidemiological Studies.
For More Information: Contact the JAMA/Archives Media Relations Department at 312-464-JAMA (5262) or email:

Media Advisory: To contact Jane F. Seward, M.B., B.S., M.P.H., call Curtis Allen at 404-639-8487.

The JAMA Network Journals

Related Vaccine Articles from Brightsurf:

Who should get the COVID-19 vaccine first?
Nineteen global health experts from around the world have proposed a new, three-phase plan for vaccine distribution -- called the Fair Priority Model -- which aims to reduce premature deaths and other irreversible health consequences from COVID-19.

Breakthrough with cancer vaccine
Scientists have developed a new cancer vaccine with the potential to activate the body's immune system to fight a range of cancers, including leukaemia, breast cancer, lung cancer and pancreatic cancers.

How to improve the pneumococcus vaccine
Pneumococcus kills 1 million children annually according to the World Health Organization.

US inroads to better Ebola vaccine
As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses.

Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
In a new study, published April 7 in mBio, researchers from the University of Iowa and the University of Georgia demonstrate that a new vaccine fully protects mice against a lethal dose of MERS, a close cousin of COVID-19.

Coronavirus Vaccine: Where are we and what's next? (video)
You might have heard that COVID-19 vaccine trials are underway in Seattle.

Why isn't there a vaccine for staph?
A study from Washington University School of Medicine in St.

Exposing vaccine hesitant to real-life pain of diseases makes them more pro-vaccine
New research from Brigham Young University professors finds there is a better way to help increase support for vaccinations: Expose people to the pain and suffering caused by vaccine-preventable diseases instead of trying to combat people with vaccine facts.

Lifetime flu vaccine?
Another year, another flu vaccine because so far scientists haven't managed to make a vaccine that protects against all strains of flu.

On the horizon: An acne vaccine
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.

Read More: Vaccine News and Vaccine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to